ES3064258T3 - Method for preparing ophthalmic preparation containing thymosin beta-4 - Google Patents

Method for preparing ophthalmic preparation containing thymosin beta-4

Info

Publication number
ES3064258T3
ES3064258T3 ES15905904T ES15905904T ES3064258T3 ES 3064258 T3 ES3064258 T3 ES 3064258T3 ES 15905904 T ES15905904 T ES 15905904T ES 15905904 T ES15905904 T ES 15905904T ES 3064258 T3 ES3064258 T3 ES 3064258T3
Authority
ES
Spain
Prior art keywords
thymosin
composition
inert gas
ophthalmic
container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES15905904T
Other languages
English (en)
Spanish (es)
Other versions
ES3064258T8 (en
Inventor
Si Young Lee
Sin Wook Kang
Ji Hye Sung
Tae Heum Um
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HLB Therapeutics Co Ltd
Original Assignee
G TreeBNT Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by G TreeBNT Co Ltd filed Critical G TreeBNT Co Ltd
Application granted granted Critical
Publication of ES3064258T3 publication Critical patent/ES3064258T3/es
Publication of ES3064258T8 publication Critical patent/ES3064258T8/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B23/00—Noble gases; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A61J1/12—Bag-type containers with means for holding samples of contents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
ES15905904T 2015-10-06 2015-12-18 Method for preparing ophthalmic preparation containing thymosin beta-4 Active ES3064258T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20150140489 2015-10-06
PCT/KR2015/013981 WO2017061663A1 (ko) 2015-10-06 2015-12-18 티모신 베타 4를 포함하는 안약의 제조방법

Publications (2)

Publication Number Publication Date
ES3064258T3 true ES3064258T3 (en) 2026-04-23
ES3064258T8 ES3064258T8 (en) 2026-05-13

Family

ID=58487995

Family Applications (1)

Application Number Title Priority Date Filing Date
ES15905904T Active ES3064258T3 (en) 2015-10-06 2015-12-18 Method for preparing ophthalmic preparation containing thymosin beta-4

Country Status (7)

Country Link
US (1) US10744088B2 (enExample)
EP (1) EP3342398B1 (enExample)
JP (2) JP6996713B2 (enExample)
KR (1) KR102487614B1 (enExample)
ES (1) ES3064258T3 (enExample)
HK (1) HK1256595A1 (enExample)
WO (1) WO2017061663A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12653779B2 (en) 2015-06-18 2026-06-16 Lenz Therapeutics Operations, Inc. Compositions and methods for the treatment of presbyopia
US20210251970A1 (en) 2018-10-10 2021-08-19 Presbyopia Therapies Inc Compositions and methods for storage stable ophthalmic drugs
BR112021006618B1 (pt) * 2018-10-10 2022-09-27 Presbyopia Therapies, Inc Composições e métodos para o tratamento da presbiopia
CN112107678B (zh) * 2020-09-30 2022-11-18 辰欣药业股份有限公司 一种含有胸腺法新的冻干组合物及其制备方法
WO2023091439A1 (en) 2021-11-17 2023-05-25 Lenz Therapeutics, Inc. Aceclidine derivatives, compositions thereof and methods of use thereof
CN115266995B (zh) * 2022-08-02 2023-10-13 兆科（广州）眼科药物有限公司 一种生发肽制剂中有关物质的分析方法
US12414942B1 (en) 2024-03-15 2025-09-16 Lenz Therapeutics Operations, Inc. Compositions, methods, and systems for treating presbyopia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150744A (en) * 1976-02-27 1979-04-24 Smith & Nephew Pharmaceuticals Ltd. Packaging
US6271216B1 (en) * 1989-07-24 2001-08-07 Allergan Stable solution of hyaluronate in a balanced salt medium
KR19980703582A (ko) * 1995-04-04 1998-11-05 가와구치 시게키 염산 프로카테롤 수용액 제제를 보지하는 패키지 및 염산 프로카테롤 수용액 제제
EP1100529B2 (en) 1998-07-30 2010-08-25 The Government of the United States of America, as repres. by the Secretary of Health and Human Services, Nat. Inst. of Health Thymosin beta 4 promotes wound repair
US6552198B1 (en) 1998-10-14 2003-04-22 Kyowa Hakko Kogyo Co., Ltd. Method of stabilizing aqueous pyrazoloacridone derivative solution
MY176923A (en) * 2004-07-30 2020-08-26 Otsuka Pharma Co Ltd Squeeze bottle and eye dropper using the same
KR20060051135A (ko) 2004-09-15 2006-05-19 니프로 가부시키가이샤 안정화된 주사용 수용액 제재
KR20080018268A (ko) * 2005-06-17 2008-02-27 리지너크스 바이오 파마소티컬스, 인코포레이티드 조직 악화, 부상 또는 손상을 치료하거나 또는 예방하기위한 엘케이케이티이티 및/또는 엘케이케이티엔티 조성물들및 그 방법
ES2288118B1 (es) * 2006-05-10 2008-11-01 Bcn Peptides, S.A. Procedimiento para sintetizar timosinas.
WO2008108927A2 (en) * 2007-03-06 2008-09-12 Regenerx Biopharmaceuticals, Inc. Methods and compositions for stabilizing polypeptides
KR20160065998A (ko) 2007-04-11 2016-06-09 바이오마린 파머수티컬 인크. 테트라하이드로바이오프테린 투여 방법, 관련 조성물 및 측정 방법
JP5990880B2 (ja) * 2011-08-31 2016-09-14 東レ株式会社 有用タンパク質組成物およびその製造方法

Also Published As

Publication number Publication date
EP3342398A1 (en) 2018-07-04
JP2020183391A (ja) 2020-11-12
KR102487614B1 (ko) 2023-01-12
HK1256595A1 (en) 2019-09-27
US20180228729A1 (en) 2018-08-16
US10744088B2 (en) 2020-08-18
ES3064258T8 (en) 2026-05-13
JP2018531905A (ja) 2018-11-01
EP3342398B1 (en) 2026-02-11
EP3342398A4 (en) 2019-03-20
JP6996713B2 (ja) 2022-02-04
KR20170041109A (ko) 2017-04-14
EP3342398C0 (en) 2026-02-11
WO2017061663A1 (ko) 2017-04-13

Similar Documents

Publication Publication Date Title
US10744088B2 (en) Method for preparing ophthalmic preparation containing thymosin beta-4
ES2408784T3 (es) Preparaciones liofilizadas de HGF
ES2905614T3 (es) Formulación de proteína de fusión recombinante
ES2279522T3 (es) Preparaciones liofilizadas de hgf.
EP3199555B1 (en) Recombinant fusion protein formulation
US10702582B2 (en) HGF preparation suitable for treatment of neurological disorders
JPWO2000072873A1 (ja) Ｈｇｆ凍結乾燥製剤
CN108671229A (zh) 一种重组人血管内皮生长因子受体-抗体融合蛋白的药物组合制剂
KR20090118030A (ko) Ｈｇｆ 제제
NO873513L (no) Nye applikasjonsformer for alfa-interferoner.
KR20120114235A (ko) 알파-1 프로테이나제 억제제에 대한 조성물, 방법 및 키트
KR101838759B1 (ko) 점안제
ES2750749T3 (es) Composiciones de Mesna liofilizadas
ES2893239T3 (es) Composición de factor de crecimiento nervioso y polvo de inyección
WO2016169455A1 (zh) 神经生长因子组合物和注射粉剂
KR100671449B1 (ko) 송아지의 제단백 혈액 추출물을 함유하는 점안용 액제조성물
TW202426032A (zh) 棘白素類似物的藥物組合物及其製備方法
HK1233189A1 (en) Hgf preparation suitable for treatment of neurological disorders
JPWO2000051626A1 (ja) 化学修飾ｇ−ｃｓｆ製剤